Hsbc Holdings PLC Organogenesis Holdings Inc. Transaction History

Hsbc Holdings PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$1.97 - $4.21 $52,435 - $112,057	26,617 New	26,617 $108,000
Q4 2022 Feb 14, 2023	BUY	$2.48 - $3.43 $4,694 - $6,492	1,893 Added 14.13%	15,294 $41,000
Q3 2022 Nov 14, 2022	SELL	$3.14 - $6.43 $9,143 - $18,724	-2,912 Reduced 17.85%	13,401 $44,000
Q2 2022 Aug 11, 2022	BUY	$4.74 - $8.15 $3,204 - $5,509	676 Added 4.32%	16,313 $81,000
Q1 2022 May 16, 2022	BUY	$6.47 - $9.57 $101,171 - $149,646	15,637 New	15,637 $121,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $505M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.